Sensitivity and secondary analyses for the RRs of neonatal and maternal outcomes associated with exposure to gabapentin compared with unexposed pregnancies after PS adjustment.
Baseline characteristics of HIV-negative and HIV-positive women (by group–those starting cART prior to conception and those starting cART after conception).
